Aveir VR Leadless Pacemaker System

DEVICE3 trials

Sponsors

Abbott Medical Devices

Conditions

ArrythmiaBradycardiaCardiac PacemakerCardiac Rhythm Disorder

Unknown Phase

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

CompletedNCT04559945

Abbott Medical DevicesBradycardia, Cardiac Rhythm Disorder

Start: 2020-11-13End: 2023-09-15Updated: 2026-05-20

Aveir VR Real-World Evidence Post-Approval Study

Active, not recruitingNCT05270499

Abbott Medical DevicesArrythmia, Bradycardia, Cardiac Pacemaker

Start: 2022-06-21End: 2034-09-30Updated: 2026-05-20

Aveir VR Coverage With Evidence Development Post-Approval Study

RecruitingNCT05336877

Abbott Medical DevicesArrythmia, Bradycardia, Cardiac Pacemaker

Start: 2022-06-21End: 2028-01-01Target: 8744Updated: 2025-07-31

Related Papers

Validation and Final Results from the First Cardiac Lead Post-Approval Study Using Real-World Data

Pragmatic and Observational Research2024-12-01

Temperature-based rate response in a leadless pacemaker system

Heart Rhythm2024-11-224 citations